HBCN Stock Overview
HealthBeacon plc, a digital therapeutics company, develops products for managing injectable medications for patients in the home in Europe, the United States, and Ireland.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
HealthBeacon plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.07 |
| 52 Week High | €1.96 |
| 52 Week Low | €0.065 |
| Beta | 1.24 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -94.07% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.81% |
Recent News & Updates
Recent updates
Here's Why HealthBeacon (ISE:HBCN) Must Use Its Cash Wisely
Jun 15
We're Keeping An Eye On HealthBeacon's (ISE:HBCN) Cash Burn Rate
Feb 15Here's Why We're Watching HealthBeacon's (ISE:HBCN) Cash Burn Situation
Nov 02HealthBeacon (ISE:HBCN) Is In A Good Position To Deliver On Growth Plans
Jul 20Companies Like HealthBeacon (ISE:HBCN) Are In A Position To Invest In Growth
Apr 05Shareholder Returns
| HBCN | IE Medical Equipment | IE Market | |
|---|---|---|---|
| 7D | 0% | -0.2% | -0.2% |
| 1Y | -94.1% | -6.2% | 15.9% |
Return vs Industry: HBCN underperformed the Irish Medical Equipment industry which returned 3.5% over the past year.
Return vs Market: HBCN underperformed the Irish Market which returned 8% over the past year.
Price Volatility
| HBCN volatility | |
|---|---|
| HBCN Average Weekly Movement | 0% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in IE Market | 5.7% |
| 10% least volatile stocks in IE Market | 2.8% |
Stable Share Price: HBCN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HBCN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 70 | n/a | www.healthbeacon.com |
HealthBeacon plc, a digital therapeutics company, develops products for managing injectable medications for patients in the home in Europe, the United States, and Ireland. Its injection care management system tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence driven data analytics. The company provides HB Wave that notifies the patient and clinician when prescription refills are required and records visual images of pill containers to measure levels of medication adherence; HB Smart Scale which enables patients to add weight monitoring to injection care management system; and Global Patient Safety Platform, a proprietary software platform that help clinicians to prescribe medication to patients.
HealthBeacon plc Fundamentals Summary
| HBCN fundamental statistics | |
|---|---|
| Market cap | €1.19m |
| Earnings (TTM) | -€14.11m |
| Revenue (TTM) | €2.24m |
0.5x
P/S Ratio-0.1x
P/E RatioIs HBCN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HBCN income statement (TTM) | |
|---|---|
| Revenue | €2.24m |
| Cost of Revenue | €1.62m |
| Gross Profit | €627.00k |
| Other Expenses | €14.74m |
| Earnings | -€14.11m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.83 |
| Gross Margin | 27.94% |
| Net Profit Margin | -628.88% |
| Debt/Equity Ratio | 0% |
How did HBCN perform over the long term?
See historical performance and comparison